Frederiksstaden Pharma ApS: Financial statements 2024
CVR: 25630483
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Frederiksstaden Pharma ApS (CVR 25630483) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -39,059 and a net result of DKK -50,518 compared with DKK -82,296 the year before. Equity in the 2024 report amounted to DKK 98,167. The solvency ratio was 24.1%.
- Gross Profit
- DKK -39,059
- Profit/Loss
- DKK -50,518
- Equity
- DKK 98,167
- Total Assets
- DKK 407,391
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -39 t. | -51 t. | 98 t. | 0 |
| 2023 | - | -80 t. | -82 t. | 149 t. | 0 |
| 2022 | - | 13 t. | 4 t. | 231 t. | 0 |
| 2021 | - | -666 t. | -1.4 mio. | 227 t. | 3 |
| 2020 | - | 2 mio. | -1.8 mio. | 1.6 mio. | 7 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Frederiksstaden Pharma ApS has published its annual report for 2023. Gross profit came to DKK -79,848, and the net result was DKK -82,296.
About Frederiksstaden Pharma ApS
Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.